机译:肺腺癌中EGFR增高和VHL丧失与患者生存不良的关系
Department of Cardiovascular Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China;
Department of Cardiovascular Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China;
Department of Thoracic Surgery, The First Affiliated Hospital, Harbin Medical University, No. 23 Youzheng Street, Harbin, 150001, China;
Department of Cardiovascular Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China;
Department of Cardiovascular Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China;
Department of Cardiovascular Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China;
Department of Thoracic Surgery, The Second Affiliated Hospital, Mudanjiang Medical College, Mudanjiang, 157010, China;
Department of Oncology, No.113 Hospital of Peop;
Copy number alteration; Lung adenocarcinoma; Survival; EGFR gain; VHL loss;
机译:肺腺癌中EGFR增高和VHL丧失与患者生存不良的关系
机译:年轻的肺腺癌患者的EGFR突变率较低且EGFR酪氨酸激酶抑制剂的疗效较差
机译:EGFR的高表达预测切除的T3阶段胃腺癌患者的存活率差,促进癌细胞存活
机译:Cerna搜索方法鉴定了EGFR DNA扩增肺腺癌患者的核激活的亚组
机译:RB1损失通过谱系可塑性加速EGFR突变体肺腺癌的获得性抗性
机译:在EGFR-TKI治疗后肺腺癌患者存活中获得的EGFR T790M突变和EGFR循环无细胞DNA的影响
机译:年轻的肺腺癌患者EGFR突变率较低,EGFR酪氨酸激酶抑制剂的疗效较差